4-aminopyridine has been researched along with Patency of the Ductus Arteriosus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thébaud, B | 1 |
| Michelakis, ED | 1 |
| Wu, XC | 1 |
| Moudgil, R | 1 |
| Kuzyk, M | 1 |
| Dyck, JR | 1 |
| Harry, G | 1 |
| Hashimoto, K | 1 |
| Haromy, A | 1 |
| Rebeyka, I | 2 |
| Archer, SL | 1 |
| Michelakis, E | 1 |
| Bateson, J | 1 |
| Olley, P | 1 |
| Puttagunta, L | 1 |
| Archer, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Liberal Versus Restrictive Platelet Transfusion for Treatment of Hemodynamically Significant Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates- A Randomized Open Label, Controlled Trial[NCT03022253] | Phase 3 | 44 participants (Anticipated) | Interventional | 2016-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for 4-aminopyridine and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Oxygen-sensitive Kv channel gene transfer confers oxygen responsiveness to preterm rabbit and remodeled human ductus arteriosus: implications for infants with patent ductus arteriosus.
Topics: 4-Aminopyridine; Adenoviridae; Animals; Animals, Newborn; Ductus Arteriosus; Ductus Arteriosus, Pate | 2004 |
Voltage-gated potassium channels in human ductus arteriosus.
Topics: 4-Aminopyridine; Charybdotoxin; Cyclooxygenase Inhibitors; Ductus Arteriosus; Ductus Arteriosus, Pat | 2000 |